We are live on ! Find out more
CLPT icon

ClearPoint Neuro
CLPT

78 hedge funds and large institutions have $76.5M invested in ClearPoint Neuro in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more capital invested

Capital invested by funds: $38M → $76.5M (+$38.5M)

46% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $695K

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

1% less ownership

Funds ownership: 25.73% → 24.73% (-1%)

9% less funds holding

Funds holding: 86 → 78 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
78
Holders Change
-8
Holders Change %
-9.3%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
21
Reduced
21
Closed
22
Calls
$1.02M
Puts
$695K
Net Calls
+$321K
Net Calls Change
+$262K

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$2.09M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.4M
3
CCM
Conway Capital Management
California
+$1.35M
4
Citigroup
Citigroup
New York
+$763K
5
EI
EAM Investors
California
+$756K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.82M
2
Northern Trust
Northern Trust
Illinois
-$1.22M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.16M
4
Citadel Advisors
Citadel Advisors
Florida
-$949K
5
Goldman Sachs
Goldman Sachs
New York
-$933K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$122K +$38.7K +4,046 +59%
Charles Schwab
52
Charles Schwab
California
$116K – – –
JP Morgan Chase
53
JP Morgan Chase
New York
$110K +$34.6K +3,612 +59%
CA
54
CoreCap Advisors
Michigan
$90.3K – – –
Fidelity Investments
55
Fidelity Investments
Massachusetts
$84.9K -$412 -43 -0.6%
Barclays
56
Barclays
United Kingdom
$63.6K +$10.6K +1,109 +24%
OC
57
Oarsman Capital
Wisconsin
$56K +$47.9K +5,000 New
CFM
58
Catalyst Funds Management
Australia
$49.3K – – –
Acadian Asset Management
59
Acadian Asset Management
Massachusetts
$42K +$36.1K +3,768 New
DF
60
Dunhill Financial
United Kingdom
$16.8K +$14.4K +1,500 New
CSB
61
City State Bank
Iowa
$9.53K – – –
Osaic Holdings
62
Osaic Holdings
Arizona
$8.13K – – –
MFT
63
Moisand Fitzgerald Tamayo
Florida
$6.07K -$38.3K -4,000 -88%
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$6K +$2.21K +231 +70%
JPWM
65
Jamison Private Wealth Management
Georgia
$3.36K – – –
National Bank of Canada
66
National Bank of Canada
Quebec, Canada
$3.07K +$2.62K +274 New
Russell Investments Group
67
Russell Investments Group
United Kingdom
$2.24K -$651 -68 -25%
NS
68
NBC Securities
Alabama
$2K – – –
BIA
69
Bell Investment Advisors
California
$1.17K – – –
AW
70
Avion Wealth
Texas
$1K – – –
Wells Fargo
71
Wells Fargo
California
$773 +$421 +44 +176%
AF
72
Allworth Financial
California
$729 – – –
Nisa Investment Advisors
73
Nisa Investment Advisors
Missouri
$729 – – –
GEA
74
Glen Eagle Advisors
New Jersey
$561 – – –
KFI
75
Key Financial Inc
Pennsylvania
$280 – – –
1 2
3
4

CLPT Hedge Fund Activity: Q3 2024 in Review

78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2024, worth a combined $76.5M — up 101% from $38M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CLPT and 14 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 21 added.

The largest buyer was Marshall Wace, adding an estimated $2.09M. The largest seller was Millennium Management, cutting an estimated $1.82M.

  • 78 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2024, down from 86 in Q2 2024.
  • Funds reported $76.5M of ClearPoint Neuro stock for Q3 2024, up 101% quarter-over-quarter.
  • 14 funds opened new ClearPoint Neuro positions in Q3 2024 and 22 closed out, a net change of -8 holders.
  • The largest ClearPoint Neuro buyer in Q3 2024 was Marshall Wace, an estimated $2.09M added.
  • The largest ClearPoint Neuro seller in Q3 2024 was Millennium Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q3 2024.